Toggle Offcanvas
...
 
Adalimumab Tenders

Adalimumab Tenders

View Adalimumab tenders, RFPs and contracts. Bid on readily available Adalimumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Adalimumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Adalimumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Adalimumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Adalimumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

25 Live Notices for Adalimumab Tenders

Showing 1 to 20

Error 500 (Server Error)!!1500.That’S An Error.There Was An Error. Please Try Again Later.That’S All We Know.
country Chile
posting date07 Feb 2025
deadline17 Feb 2025
Etanercept 50Mgml Sol.Iny Jrpautoiny 1000020735
country Chile
posting date05 Feb 2025
deadline26 Feb 2025
Adalimumab 20Mg Sol.Iny.Jrpautoin 1000020738
country Chile
posting date05 Feb 2025
deadline17 Feb 2025
Supply Of Medicines Pm
country Chile
posting date04 Feb 2025
deadline13 Feb 2025
Supply of Medicine and Medical / Surgical equipments : Adalimumab Injection 40mg/0.8mL Prefilled etc .
country Sri Lanka
posting date03 Feb 2025
deadline10 Feb 2025
Gsp Medicine Supply Ministerial Program Non-Intermediate
country Chile
posting date31 Jan 2025
deadline10 Feb 2025
Prescription Service Drug Insurance Supplement Competition
country Saudi Arabia
posting date30 Jan 2025
deadline03 Nov 2025
Brentuximab Vedotina 50 Mg Liof Iny Fam 1000020662
country Chile
posting date29 Jan 2025
deadline27 Feb 2025
Adalimumab Supply (Doe)
country Spain
posting date27 Jan 2025
deadline11 Feb 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Adalimumab (Atc Code According To Who: L04Ab04)
country Germany
posting date20 Jan 2025
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Adalimumab (Atc Code According To Who: L04Ab04)
country Germany
posting date20 Jan 2025
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Adalimumab (Atc Code According To Who: L04Ab04)
country Germany
posting date20 Jan 2025
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Adalimumab (Atc Code According To Who: L04Ab04)
country Germany
posting date20 Jan 2025
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Adalimumab (Atc Code According To Who: L04Ab04)
country Germany
posting date21 Jan 2025
deadline30 Nov 2026
Medicinal Product With The Active Ingredient Adalimumab
country Czech Republic
posting date10 Jan 2025
deadline10 Feb 2025
Procurement Of The Drug - Adalimumab For The Needs Of The Zenica Cantonal Hospital For A Period Of 3 (Three) Years (Tender No. 11-150/24)
country Bosnia and Herzegovina
posting date07 Jan 2025
deadline24 Feb 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Dec 2024
deadline02 Dec 2026
Pharmaceutical Contracts With Accession Option
country Germany
posting date15 Nov 2024
deadline01 Nov 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Adalimumab
country Germany
posting date11 Nov 2024
deadline10 Nov 2026

Share Share this page